© John Wiley & Sons Ltd
Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 0.833
ISI Journal Citation Reports © Ranking: 2014: 65/122 (Statistics & Probability); 223/255 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.
David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.
David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.
Recently Published Articles
- Confidence intervals for the symmetry point: an optimal cutpoint in continuous diagnostic tests
Mónica López-Ratón, Carmen Cadarso-Suárez, Elisa M. Molanes-López and Emilio Letón
Article first published online: 12 JAN 2016 | DOI: 10.1002/pst.1734
- On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development
Kevin Carroll and Robert Hemmings
Article first published online: 6 JAN 2016 | DOI: 10.1002/pst.1733
- Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs
Thu Thuy Nguyen, Henri Bénech, Marcel Delaforge and Natacha Lenuzza
Article first published online: 22 DEC 2015 | DOI: 10.1002/pst.1731
- Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate information
Jianming Wang, Chunlei Ke, Zhinuan Yu, Lei Fu and Bruce Dornseif
Article first published online: 22 DEC 2015 | DOI: 10.1002/pst.1732